Research desk

A peptide news feed that treats sources with respect

We keep the stream editorial and source-first: regulatory updates, clinical developments, and research headlines, without mixing them into sales-y ticker copy.

Once-Weekly Tirzepatide vs Semaglutide for Weight Management: Head-to-Head Meta-Analysis

A network meta-analysis of 18 randomised controlled trials found tirzepatide 15 mg to produce greater mean weight loss (–21.4 kg) versus semaglutide 2.4 mg (–15.9 kg) at 68 weeks, with comparable safety profiles across both dual and single GLP-1 receptor agonists.

Mar 20, 2026Mar 20, 2026

tirzepatidesemaglutideGLP-1weight-management